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Abstract
Background: Endogenous peptides such as neuropeptides are involved in numerous biological processes in the
fully developed brain but very little is known about their role in brain development. Japanese quail is a commonly
used bird model for studying sexual dimorphic brain development, especially adult male copulatory behavior in
relation to manipulations of the embryonic endocrine system. This study uses a label-free liquid chromatography
mass spectrometry approach to analyze the influence of age (embryonic days 12 vs 17), sex and embryonic day 3
ethinylestradiol exposure on the expression of multiple endogenous peptides in the developing diencephalon.
Results: We identified a total of 65 peptides whereof 38 were sufficiently present in all groups for statistical
analysis. Age was the most defining variable in the data and sex had the least impact. Most identified peptides
were more highly expressed in embryonic day 17. The top candidates for EE2 exposure and sex effects were
neuropeptide K (downregulated by EE2 in males and females), gastrin-releasing peptide (more highly expressed in
control and EE2 exposed males) and gonadotropin-inhibiting hormone related protein 2 (more highly expressed in
control males and displaying interaction effects between age and sex). We also report a new potential
secretogranin-2 derived neuropeptide and previously unknown phosphorylations in the C-terminal flanking
protachykinin 1 neuropeptide.
Conclusions: This study is the first larger study on endogenous peptides in the developing brain and implies a
previously unknown role for a number of neuropeptides in middle to late avian embryogenesis. It demonstrates
the power of label-free liquid chromatography mass spectrometry to analyze the expression of multiple
endogenous peptides and the potential to detect new putative peptide candidates in a developmental model.
Background
Bird models have been instrumental to the overall
understanding of neural sex differences and endocrine
influences on brain development [1,2]. Japanese quail is
a commonly used bird model for studying sex-specific
brain development and behavior, especially the influence
of the hormonal milieu during early brain development
on sexual behaviour [3-5]. Sex-specific neural develop-
ment has traditionally been associated with sex hor-
mones produced by the gonads. Exogenous estrogen
exposure before embryonic day 12 (ed12) causes demas-
culinization of the male sexual behaviour in Japanese
quail [3,5], which shows the important role of sex
hormones in brain differentiation. Several studies in
songbirds have shown that there are exceptions to this
classical model [6-9], implicating an intrinsic genetic
influence on sex-specific neural development. Our pre-
vious studies on gene expression in early chicken [10]
and quail embryos (ongoing) also indicate a sex-specific
brain development that is at least partly independent of
the influence of gonadal hormones. Quail ed12 corre-
sponds roughly to chicken ed14 which is close to the
developmental stage when gonad derived plasma testos-
terone levels peak (~ed13.5) in male embryos and the
endocrine hypothalamic-pituitary-gonadal (HPG) axis
becomes established [11-13]. Endogenous gonad derived
plasma estradiol levels increase gradually in female
chicken embryos until ~ed13.5 where they increase
markedly [14,15]. Male chicken embryo plasma estradiol
levels are significantly lower than female levels at all
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nounced after ed13.5 [15]. The establishment of the
male HPG axis is believed to be dependent on both
hypothalamic gonadotropin-releasing hormone release
and opioid peptide regulation [12]. Several endogenous
peptides, including opioid peptides, are messengers with
sex-specific activity, some of them being stored and
secreted in an endocrine-like manner [16]. Opioid pep-
tide dependent pain and analgesia [17] are well known
examples of neural sex differences. Pain and analgesia
are conditions that are sensitive to neonatal alterations
in gonadal steroid hormones [18]. Studies using the
opioid receptor antagonist naloxone on the medial pre-
optic area (POM) in the anterior diencephalon point to
a role for opioid peptides in the regulation of both avian
and mammalian sexual behavior [19-21].
A group of neuropeptides may have the same pre-
cleavage protein precursor in common, meaning that
one gene may code for several peptides with different
functions. Although genome information from different
species has facilitated prediction of putative precursor
cleavage sites and peptide/precursor amino acid
sequences, little is known about the expression levels of
different peptides under different conditions. This is
especially true regarding the peptidome content in the
developing brain. The sequencing of the chicken gen-
ome has enabled prediction and expression analysis of
neuropeptides in avian models such as Japanese quail.
Neuropeptidomics is the technological approach for
detailed analysis of endogenous peptides in the brain.
Recently, a novel approach to study a large number of
neuropeptides using nL/min flow liquid chromatography
(nanoLC) electrospray ionization mass spectrometry was
developed to investigate the endogenous neuropeptide
content of brain tissue samples from rats and mice
[22-24].
The aims of this study were to characterize the endo-
genous peptide content of the diencephalon including
the sexually dimorphic area POM in the developing
quail brain and to analyze how its expression is related
to age, sex and the effect of ethinylestradiol (EE2)e x p o -
sure. Quail ed12 diencephalon was chosen as both the
stage of development and the tissue are of interest in
this context. Ed12 is at the end of the sensitivity period
for embryonic estrogen exposure leading to behavioral
alterations in male copulatory behavior [5] and likely in
the time period when the male endocrine HPG axis
becomes established and a more marked increase of
female estradiol synthesis occurs. Quail ed17 is some-
what before hatching and a time where the male
embryos lost their sensitivity to exogenous estradiol and
their sex specific brain and neuroendocrine development
has become established. The detection of neuropeptides
and the quantification of their expression levels were
done using liquid chromatography and ion trap mass
spectrometry together with a label-free approach.
Results
Peptide identification
Japanese quail embryonic diencephalon protein samples
from 38 individuals were separated by molecular weight,
obtaining < 10 kD samples. These samples were then
examined using nano LC coupled to an ESI-LTQ MS
system or an LTQ-FTICR system. A total of 65 peptides
were identified (Table 1) of which 38 (Table 2) were
present in a sufficient number of individuals to enable
expression profiling (see below). Among the 65 peptides,
61 were derived from neuropeptides or neuropeptide
precursor proteins. The four remaining peptides
belonged to CRMP-2, FKBP5 (also called PPIA), Stath-
min and Thymosin beta.
Expression profiling
A subset of the LTQ-MS samples were divided into eight
groups by sex (male vs female), age (ed12 vs ed17) and
EE2-exposure (tissues collected from ed12 and ed17
males and females) with four to five samples in every
group. The samples were ed12 male controls (n = 5),
ed12 female controls (n = 4), ed12 male EE2 exposed
(n = 4), ed12 female EE2 exposed (n = 4), ed17 male con-
trols (n = 4), ed17 female controls (n = 4), ed17 male EE2
exposed (n = 4) and ed17 female EE2 exposed (n = 5).
The alignment of peptide spectra was performed using
the DeCyder MS software. Expression data for 204 pep-
tides, whereof 38 identified, was first analyzed by unsu-
pervised methods (hierarchical clustering, principal
component analysis, PCA) and then by a supervised
method (Partial Least Squares Discriminant Analysis,
PLS/DA). A clear separation between ed12 and ed17 pep-
tide expression was visible in a hierarchical clustering
(Figure 1A) of all eight experimental groups with the
majority of the identified peptides being more highly
expressed in ed17 than in ed12 diencephalon (Figure 1B).
A similar pattern was detected with PCA (Figure 1C,
additional file 1).
Both analyses indicate a weak separating effect of EE2
exposure in ed12 samples. PLS/DAs were conducted to
explore the maximized separation between groups
regarding age, sex and EE2 exposure. There were no
successful models separating all three parameters (sex,
age and EE2) leading to a PLS/DA model for age and
EE2 exposure (Figure 2, additional file 2). The effect of
EE2 exposure was more distinct on ed12 than on ed17
(Additional file 3). A three-dimensional PLS/DA score
plot (Figure 2A) shows the separation of age (ed12 and
ed17) and EE2 exposure (controls, C and exposed, E),
independently of sex (ed12C, ed12E, ed17C, ed17E),
with the second and third component being most
Scholz et al. BMC Developmental Biology 2010, 10:30
http://www.biomedcentral.com/1471-213X/10/30
Page 2 of 16Table 1 Peptides identified by LTQ and FTICR-MSMS in quail diencephalon.
Precursor Peptide MH+ Sequence Comment PCA & PLS/DA
1
Acyl-CoA binding protein ODN peptide 1637.56 TVGDVNTDRPGMLDF Yes
Cerebellin-1 pre. Cerebellin-1 1632.85 SGSAKVAFSAIRSTNH Yes
Cerebellin-2 pre. Cerebellin-2 1620.80 SGSAKVAFSATRSTNH
Cerebellin-4 pre. Cerebellin-4 1451.70 ANSKVAFSAVRSTN Yes
Cerebellin-4 1267.36 SKVAFSAVRSTN Yes
Gastrin-releasing peptide GRP 1766.69 APLQPGGSPALTKIYPR Yes
GRP 1608.89 APLQPGGSPALTKIYP
Gonadotropin-inhibiting hormone GnIH propep 1743.83 SVPISLSQGVQESEPGM
GnIH-RP2 1723.97 SPLARSSIQSLLNLPQ
GnIH-RP2 1426.80 ARSSIQSLLNLPQ Yes
Glucagon family neuropeptides PACAP27 1573.73 HIDGIFTDSYSRY
Neuropeptide Y (NPY) pre. NPY 1443.81 SSPETLISDLLLR
Prepronociceptin (PNOC) pre Precursor 1226.82 AVASPLQVSELL Yes
Nociceptin 1981.07 YGGFIGVRKSARKWNNQ Yes
Nociceptin 1154.63 YGGFIGVRKSA Yes
Nociceptin 996.56 YGGFIGVRK
Neuropeptide1 1981.05 GSWPAARGVQ Yes
Neuropeptide2 1702.86 FSEFLKQYLGMSPR Yes
Neuropeptide2 1555.79 SEFLKQYLGMSPR Yes
Proenkephalin A (PENK) pre Precursor 2218.94 MDELYHPESEDEANGGEILA*
Precursor 2147.91 MDELYHPESEDEANGGEIL*
Precursor 2087.90 DELYHPESEDEANGGEILA*
Precursor 1972.44 ELYHPESEDEANGGEILA* Yes
Precursor 1901.84 ELYHPESEDEANGGEIL*
Precursor 1843.83 LYHPESEDEANGGEILA*
Precursor 1730.75 YHPESEDEANGGEILA*
Precursor 1659.72 YHPESEDEANGGEIL*
Precursor 1496.65 HPESEDEANGGEIL*
Precursor 1448.69 VGRPEWWLDYQ**
Precursor 1387.62 SPELEDEAKELQ* Yes
Precursor 1259.90 SPELEDEAKEL* Yes
Precursor 1203.57 ELEDEAKELQ*
Precursor 1074.99 LEDEAKELQ* Yes
MERF 877.40 YGGFMRF Yes
MERSL 930.45 YGGFMRSL Yes
Proenkephalin B (PENK) pre Precursor 1028.80 PKLKWDNQ Yes
Protachykinin 1 (PPT) pre C-term flanking peptide (CTFP) 1741.07 SLNSGSSERSIAQNYE Yes
C-term flanking peptide (CTFP) 1821.77 SLNSGSSERSIAQNYE S6/7(p) Yes
C-term flanking peptide (CTFP) 1900.26 SLNSGSSERSIAQNYE S6/7, S10(p) Yes
Substance P Yes
Neuropeptide K 947.42 DAGYGQISH Yes
Neuropeptide K 832.40 AGYGQISH
Neurokinin A 1133.87 HKTDSFVGLM M-amide Yes
Secretogranin-1 pre Secretogranin1- propep 1725.81 QYDKMDQLAQLLNY Pyroglutamic Acid
Secretogranin1 1357.54 IHEGEEGEAEEE Yes
Secretogranin-2 pre Secretoneurin 2064.99 TNEIVEEQYTPQSLATLE
Secretoneurin 1650.79 TNEIVEEQYTPQSL Yes
Secretoneurin 1537.70 TNEIVEEQYTPQS
Secretogranin2 1255.59 SGKLSFLEDEM
Secretogranin2 1124.55 SGKLSFLEDE Yes
Secretogranin2 880.478 SGKLSFLE
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(Figure 2B-D). Next, a virtual importance in the projec-
tion (VIP) (Figure 3) was plotted to see how much the
identified and unidentified peptides influence the differ-
ent class separations in the PLS/DA. The preprotachyki-
nin 1 peptide neuropeptide K (PPT NPK, VIP 1.59) was
most important for overall separation among the identi-
fied peptides, followed by a peptide derived from
CRMP-2 (VIP 1.45). These two peptides also display a
significantly interaction effect when using moderated F-
statistics (see below) (Table 2). Four unidentified pep-
tides (VIP 1.6-1.85) were more relevant than NPK (data
not shown). NPK, the top PLS/DA candidate for overall
effects on classes based on age and EE2 exposure, was
also the most influential among ed12 samples (see Addi-
tional file 3).
Multivariate analysis methods such as PCA and PLS/DA
are efficient for illustrating general trends and patterns in
complex data but more limited in determining the signif-
icance/effect for single factors (peptides). An F-test was
used to detect statistically significant (adjusted p < 0.05)
differences in singular peptide expression between groups
regarding the response variables age, EE2 exposure and
sex. The age differences among identified peptides were
dominated by a general upregulation between ed12 and
ed17 (Figure 1B, Table 2). There were a few exceptions,
such as NPK and the cerebellin derived peptides (Table
2). Only few peptides were significantly affected by either
sex or EE2 exposure (Table 2). The top EE2 candidates
were NPK and the CRMP-2 derived peptide (Figure 4).
This was also indicated by their localization (peptides
#118, 217) in the PLS/DA VIP (Figure 3) and the loading
scatter plot (Figure 2C-D) where they are most promi-
nent in separating control samples (ed12C, ed17C) from
EE2 samples (ed12E, ed17E). The CRMP-2 peptide dis-
plays EE2 induced downregulation of expression in males
at ed12 and ed17 (in average ~57%), whereas NPK is
downregulated in both males and females at ed12 and
ed17 (in average 50%). Peptides derived from gastrin-
releasing peptide (GRP; APLQPGGSPALTKIYPR) and
gonadotropin inhibitory hormone related peptide 2
(GnIH-RP2) were the top candidates for sex specific dif-
ferences (Figure 4). GRP was more highly expressed (in
average 66%) in all male groups compared to their
respective female groups independent of EE2 exposure
( F i g u r e4 )a n dG n I H - R P 2w a sm o r eh i g h l ye x p r e s s e d( i n
average 52%) in ed12 males and in ed17 control males.
Secretogranins
Peptides from three secretogranins (SCG1, SCG2, and
S C G 5 )w e r ei d e n t i f i e d( T a b l e1 ) .T w oo u to fs i x
SCG2 peptides were detected in all samples. The
two SCG2 derived peptides (TNEIVEEQYTPQSL and
SGKLSFLEDE) behave in different manners as seen by
F-test statistics (the former being non-significant and the
later significant, F-test statistics, adjusted p < 0.05). Both
show an age effect, becoming more highly expressed in
ed17 but only SGKLSFLEDE shows a significant interac-
tion effect and approaches significance for a treatment
effect (t-test p-value 0.062). SGKLSFLEDE is located
between two basic amino acid cleavage sites (KR, RR)
and corresponds to human SCG2 285-295 (Figure 5).
The full peptide probably includes an additional C-term-
inal methionine (SGKLSFLEDE M) if one considers the
full sequence between the cleavage sites. Such a peptide
was also discovered (Table 1) but its presence across all
samples was insufficient form a t c h i n gp u r p o s e s .T h e
amino acid sequence of the secretogranin-1 (chromagra-
nin B) peptide (IHEGEEGEAEEE) is less conserved
between birds and mammals and the peptide as such see-
mingly unaffected by age. The peptide is located in a
non-conserved sequence region of secretogranin-1 (data
Table 1: Peptides identified by LTQ and FTICR-MSMS in quail diencephalon. (Continued)
Secretogranin-5 pre C-terminal peptide (CTP) 1772.96 SVNPYLQGKRLDNVVA Yes
C-terminal peptide (CTP) 1701.63 SVNPYLQGKRLDNVV Yes
Somatostatin pre SMS-propep 1256.71 SLAAAAGKQELAK
SMS-14 1409.18 KNFFWKTFTSC Yes
SMS-14 1019.90 FWKTFTSC Yes
SMS-28 1226.61 SANSNPALAPRE Yes
SMS-28 1097.57 SANSNPALAPR
SMS-28 1139.58 ANSNPALAPRE
Vasoactive intestinal peptide VIP 1219.7 AVFTDNYSRF Yes
CRMP-2 1210.81 APPGGRANITSLG Yes
FKBP5 1712.77 ANAGPNTNGSQFFICTA Yes
Stathmin 1358.74 ASGQAFELILGPR
Thymosin beta 1566.84 SDKPDMAEIEKFDK Yes
1 Partial Least Square Discriminant Analysis * Propeptide to Met-enkephalin.
**Propeptide to Leu-enkephalin
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Precursor Peptide Sequence F-test
FDR adj. p-
value
1
Age effect
log2
fold
change
Sex effect log2 fold
change
EE2 effect
log2 fold
change
Interactions
2
ACBP ODN-peptide TVGDVNTDRPGMLDF p < 0.001 3.80*** p < 0.01
CBLN1 Cerebellin-1 SGSAKVAFSAIRSTNH n.s. n.s.
CBLN4 Cerebellin-4 ANSKVAFSAVRSTN n.s. n.s.
CBLN4 Cerebellin-4 SKVAFSAVRSTN n.s. n.s.
GRP GRP APLQPGGSPALTKIYPR p < 0.001 1.08*** -0.59*** n.s.
GnIH GnIH-RP2 ARSSIQSLLNLSQ p < 0.001 3.41*** -0.94* p < 0.01
PNOC PNOC AVASPLQVSELL p < 0.001 1.62*** n.s.
PNOC Nociceptin YGGFIGVRKSARKWNNQ p < 0.001 1.56*** p < 0.05
PNOC Nociceptin YGGFIGVRKSA p < 0.01 0.75*** 0.45* p < 0.05
PNOC Neuropeptide1 GSWPAARGVQ p < 0.001 1.24*** 0.29* n.s.
PNOC Neuropeptide2 FSEFLKQYLGMSPR p < 0.001 1.17*** n.s.
PNOC Neuropeptide2 SEFLKQYLGMSPR p < 0.001 2.24*** n.s.
PENK Precursor ELYHPESEDEANGGEILA n.s. n.s.
PENK Precursor SPELEDEAKELQ p < 0.001 0.92*** n.s.
PENK Precursor SPELEDEAKEL p < 0.001 2.36*** 0.57* n.s.
PENK Precursor LEDEAKELQ p < 0.001 1.76*** n.s.
PENK Precursor VGRPEWWLDYQ p < 0.001 0.96*** 0.51* p < 0.05
PENK MERF YGGFMRF p < 0.001 1.59*** n.s.
PENK MERSL YGGFMRSL p < 0.001 0.95*** 0.35* n.s.
PENKB Precursor PKLKWDNQ p < 0.01 2.36*** n.s.
PPT CTFP SLNSGSSERSIAQNYE n.s. 0.66** n.s.
PPT CTFP (1P) SLNSGSSERSIAQNYE p < 0.001 1.28*** n.s.
PPT CTFP (2P) SLNSGSSERSIAQNYE p < 0.05 0.92*** n.s.
PPT SP RPRPQQFFGLM p < 0.001 1.80*** n.s.
PPT NPK DAGYGQISH n.s. -0.99*** p < 0.05
PPT NKA HKTDSFVGLM p < 0.001 1.78*** n.s.
SCG1 SCG1 IHEGEEGEAEEE n.s. n.s.
SCG2 Secretoneurin TNEIVEEQYTPQSL n.s. 0.40* n.s.
SCG2 SCG2 SGKLSFLEDE p < 0.001 2.40*** p < 0.05
SCG5 CTP SVNPYLQGKRLDNVVA p < 0.001 1.12*** 0.18* n.s.
SCG5 CTP SVNPYLQGKRLDNVV p < 0.001 2.64*** n.s.
SMS SMS-14 KNFFWKTFTSC p < 0.001 2.62*** p < 0.05
SMS SMS-14 FWKTFTSC p < 0.001 2.70*** n.s.
SMS SMS-28 SANSNPALAPRE p < 0.001 1.03*** n.s.
VIP VIP AVFTDNYSRF p < 0.001 2.76*** n.s.
CRMP-2 APPGGRANITSLG p < 0.01 -0.82** p < 0.01
PPIA/FKBP12 ANAGPNTNGSQFFICTA p < 0.001 -0.55*** -0.29* n.s.
Thymosin
beta
SDKPDMAEIEKFDK n.s. n.s.
1. The F-test describes the significance of the linear model that incorporates the three parameters in this study: age (ed12 and ed17, sex (male and female), and
exposure (controls and EE2 exposed). There are three levels of statistical significance for the parameter effects: p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). A
minus sign (-) in the age effect column means that the peptide is more highly expressed in ed12 than ed17. A minus sign (-) in the sex effect column means
that the peptide is more highly expressed in males compared to females. A minus sign (-) in the EE2 effect column means that the peptide is more highly
expressed in controls compared to exposed.
2. The significance of the interaction effects was calculated by Walds F-test. n.s. means non-significant.
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Page 5 of 16not shown) and no deduction about relevance or func-
tionality was possible.
Protachykinins
Among the peptides identified, several were part of the
protachykinin 1 precursor (designated PPT). Representa-
tive peptide sequences for all peptide forms (substance
P [SP], NPK, neurokinin A [NKA] and C-terminal flank-
ing peptide [CTFP]) except neuropeptide gamma were
detected. FTICR-MS enabled us to detect two previously
unknown phosphorylations on the C-terminal flanking
peptide (CTFP), on S6 or S7 (single phosphorylated;
Figure 6A) and S10 (double phosphorylated with S6/7;
Figure 6B). The detection of the truncated NPK
sequence DAGYGQISH (Figure 6C) shows that quail
has the same sequence deletion in its Protachykinin
gene as seen in chicken compared to mammals. The
log2 ion intensity levels for non-phosphorylated and
Figure 1 Unsupervised hierarchical clustering and principal component analysis.( A) Visualization of group differences (ed12MC, ed12FC,
ed12ME, ed12FE, ed17MC, ed17FC, ed17ME, ed17FE) for 204 peptides, using two-way clustering of the log2 ratio (Xclass-Xtot) between the
group median value (Xclass) and the total median value for every peptide (Xtot). (B) One-way clustering of 38 identified peptides. Positive values
are colored red, negative are green. (C) Principal component analysis using two components (C1, C2). The last letter(s) in the group definitions
ed12/17XX stand for M = male, F = female, C = controls, E = ethinylestradiol exposed. # designates the peptide numbers in the data set.
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similar (log2 ion intensity ~18-19) across all groups
whereas the expression of the double-phosphorylated
isoform was much lower (log2 ion intensity ~12-13).
Discussion
T h e r ei sv e r yl i t t l ek n o w na b o u tn e u r o p e p t i d ee x p r e s -
sion patterns and regulation in the developing embryo-
nic brain. This is the first peptidomics study on
neuropeptide expression in the developing avian brain.
A total of 65 peptides from the embryonic quail dience-
phalon were identified (Table 1). Using the minimum
matching criteria of max one missing sample per group
resulted in 204 matched peptides, including 38 identi-
fied. These were plotted for differences related to age
(ed12 and ed17), sex and EE2 exposure. The general pat-
terns in the data set were explored using unsupervised
and supervised multivariate analysis and unsupervised
hierarchical clustering. These methods demonstrated a
clear age separation between ed12 and ed17 individuals.
The fact that most identified peptides were more highly
expressed in ed17 compared to ed12 was not represen-
tative for all plotted peptides (Figure 1A-B, Table 2).
The PCA and hierarchical clustering also revealed a less
distinctive but still discernable separation of control and
EE2 exposed individuals, although mainly at ed12. Over-
all, the data indicates that the ed12 quail diencephalon
shows a more distinct EE2 sensitive and sex peptide
expression pattern as compared to ed17 (Figure 1, Addi-
tional file 3). If true, it may be correlated with the estab-
lishment of the HPG axis occurring at this
developmental stage in male quail embryos [12,13]. No
overall sex-specific patterns were detected, which was
somewhat unexpected considering the sexual dimorphic
Figure 2 PLS/DA on age and EE2 exposure using 204 quail peptides.( A) Three-dimensional score plot for all observations using the first
three components (explaining ~75% of the data) in a model on age and EE2 exposure effects. The PLS/DA model uses the dummy variables
DA1 (ed12C, red color), DA2 (ed12E, green color), DA3 (ed17C, blue color), and DA4 (ed17E, black color). In (B), the second and third
components are combined in a score scatter plot, separating controls (red and blue triangles) from EE2 individuals (green and black boxes). The
influence of identified peptides on the positioning of samples in the score scatter plot is seen in the loading scatter plot (C). The 38 identified
peptides in the loading plot are listed in (D). Score/loading axes for DC2 and DC3 are designated t(2)/w*c(2) and t(3)/w*c(3) respectively. ed12/
17C designates ed12/17 controls and ed12/17E designates ethinylestradiol exposed.
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observed in birds on the mRNA level [10,25,26]. The
mRNA differences are mainly based on gene dosage
effects from the Z chromosomes (males ZZ; females
ZW). Only one peptide (GRP) in our data was derived
from a gene located on the Z chromosome, possibly
explaining the absence of large scale sex differences.
Interestingly, the sex chromosome Z derived GRP pep-
tide was the top candidate for sex specific peptide
expression and was significantly more highly expressed
in males compared to females in both controls and EE2
exposed individuals. The absence of general sex
differences was also unexpected in relation to the detec-
tion of candidates for the demasculinizating EE2 effects
on the copulatory behavior in adult males following
embryonic estrogen exposure [5,27].
Most of the identified peptides were part of larger
neuropeptide precursor proteins. Peptides derived from
the same secretogranin-2 precursor displayed expression
differences indicating peptide specific regulation. Both
peptides were more highly expressed in ed17 but only
SGKLSFLEDE was significantly affected over all groups
(F-test statistics, adjusted p < 0.001) with a significant
interaction effect and near significant EE2 treatment
Figure 3 Virtual importance in the projection plot (VIP). The VIP shows the role of identified peptides in the separation of the four age and
EE2 exposure PLS/DA classes (ed12C, ed12E, ed17C, ed17E). The preprotachykinin-1 neuropeptide K (NPK) is the top candidate among identified
peptides for being affected by both age and EE2 exposure. Values above one are the most relevant for the separation of all classes. Unidentified
peptides are not shown. Error bars designate confidence intervals derived by jack knifing.
Figure 4 Candidate diencephalon peptides sensitive to sex differences or EE2. Visualization of the differences of candidate peptides (NPK, CRMP-
2, GnIH-RP2, and GRP) between all eight groups (ed12MC, ed12FC, ed12ME, ed12FE, ed17MC, ed17FC, ed17ME, ed17FE) as calculated (Xclass-Xtot)f o r
the hierarchical clustering in figure 1. The stars designate significance levels (*** p < 0.001, ** p < 0.01 and * p < 0.05) for the different factors in the
model.
a FDR adjusted p-value significance for F-test. Interaction effects were tested using Wald F-test. The last letters in the group definitions ed12/
17XX stand for M = male, F = female, C = controls, E = ethinylestradiol exposed.
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Page 8 of 16effect (p-value 0.062). The positioning of SGKLSFLEDE
between basic amino acid pairs (KR and RK, Figure 5A)
and its expression pattern compared to Secretoneurin
indicates that it possesses a specific biological function
and makes it a potential new avian neuropeptide candi-
date. Besides SGKLSFLEDE, two other forms
(SGKLSFLE and SGKLSFLEDEM) were also detected,
although not in all the samples. The later, SGKLSFLE-
DEM is probably the complete peptide as it represents
the complete sequence between the two cleavage sites in
the precursor protein.
Previous studies have demonstrated that opioid pep-
tides are involved in aggressive and sexual behaviors in
adult Japanese quail [21,28] and also in the
establishment of the male chicken embryonic HPG axis
[12]. We detected a large number of proenkephalin pre-
cursor (PENK) derived peptides (Table 1, Additional file
4), although the majority were propeptides located in
front of the opioid peptides. None of the identified
opioid peptides (MERF or MERSL) differed significantly
between groups except with regard to age. The detec-
tion of Met-Enkephalin (Met-Enk) and Leu-Enkephalin
(Leu-Enk) propeptides indicates that Met-Enk and Leu-
Enk also are expressed in the developing diencephalon.
Their absence may be explained by the fact that their
short sequences make it more difficult to detect them
w i t hL C - M S .T h ep r e s e n c eo f the complete Leu-Enk
propeptide (VGRPEWWLDYQ) in all groups and it
Figure 5 Japanese quail secretogranins.( A) Overview of avian secretogranin-2 (based on chicken sequence XP_422624) showing its granin
protein domain and the position and multiple sequence alignment to other species for two identified peptides: TNEIVEEQYTPQSL (Secretoneurin
peptide) and SGKLSFLEDE. Bt is Bos taurus,S si sSus scrofa,H si sHomo sapiens,M mi sMus musculus,G gi sGallus gallus,X li sXenopus leavis, and
Dr is Danio rerio.( B) MS/MS fragmentation graph for SGKLSFLEDE in GPM browser. RI stands for relative intensity. C, Visualization of expression
differences between the groups as calculated (Xclass-Xtot) for the hierarchical clustering in figure 1. The stars designate significance levels (*** p
< 0.001, ** p < 0.01 and * p < 0.05) for the different factors in the model.
a FDR adjusted p-value significance for F-test. Interaction effects were
tested using Wald F-test. The last letters in the group definitions ed12/17XX stand for M = male, F = female, C = controls, E = ethinylestradiol
exposed.
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Page 9 of 16Figure 6 The preprotachykinin-1 peptides. SLNSGSSERSIAQNYE is similar to the C-terminal flanking peptide (CTFP) in mammalian
protachykinin 1. Two previously unknown serine phosphorylations at positions S6 or S7 and S10 were discovered. (A) FTICR derived MS/MS
spectra for single phosphorylated form (Mw 1820) at S6 or S7 and (B) S10 (Mw 1900.3). Amino acid sequence alignment (C) between chicken
(continuous sequence in black color) and human (red text) preprotachykinin 1 precursor shows the differences between birds and mammals in
the detected tachykinins, especially neuropeptide K (NPK). (D) Visualization of differences between the groups as calculated (Xclass-Xtot) for the
hierarchical clustering in figure 1. The stars designate significance levels (*** p < 0.001, ** p < 0.01 and * p < 0.05) for the different factors in the
model.
a FDR adjusted p-value significance for F-test. Interaction effects were tested using Wald F-test. The last letters in the group definitions
ed12/17XX stand for M = male, F = female, C = controls, E = ethinylestradiol exposed.
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Page 10 of 16being significantly affected by age and EE2 exposure plus
exhibiting interaction effects (Table 2) may indicate that
Leu-Enk also is differentially expressed. Among the pep-
tides derived from another large neuropeptide precursor
protein, Preprotachykinin 1, we identified two previously
unknown phosphorylations on the C-terminal flanking
peptide (CTFP), on S6 or S7 (single phosphorylated; Fig-
ure 6A) and S10 (double phosphorylated with S6/7; Fig-
ure 6B). Quail SP possesses the same Arg for Lys
substitution at the third position compared with humans
as previously described in chicken [29], alligator [30]
and Burmese python [31] whereas quail NKA is identi-
cal to chicken, alligator, Burmese python and human
NKA [31]. NKA is the ten amino acid long C-terminal
part of NPK (36 amino acids) in mammals. The LC-MS
detection and identification of the truncated NPK
sequence DAGYGQISH (Figure 6C) shows that quail
has the same sequence deletion in its Protachykinin
gene compared to mammals as seen in chicken. Antisera
against a mammalian NPK fragment which encompasses
some of the chicken NPK sequence shows immunoreac-
tivity in the developing chicken embryonic spinal cord
which weakens after hatching [32]. The nine amino acid
long quail NPK could work in a functionally inert pro-
peptide fashion to NKA in quail considering that NPK
is converted into NKA in mammals [33]. It is not clear
if the truncated avian NPK has a biological function
although it is indicative that it is the top candidate for
influencing overall separation in the multivariate data-
sets with regard to age and EE2 exposure, especially at
ed12 (Figures 2 and 3, Additional file 3) and becomes
significantly downregulated in all groups after EE2 expo-
sure (Figure 4, Table 2). The different age dependent
expression patterns seen in our data for NPK and NKA
(NPK is unaffected by age whereas NKA is significantly
upregulated) can also be interpreted as involvement in
separate biological processes during diencephalon devel-
opment. NPK is known to regulate gonadotropin secre-
tion in the mammalian hypothalamus [34], and our data
indicates that this may also be true for avian diencepha-
lon development.
There were only few peptides exhibiting sex differences
in expression, the top candidates being the GRP and
GnIH-RP2 peptides. The first 17 amino acids of GRP was
as previously mentioned the only ChrZ-derived peptide
detected in our data and it was generally more highly
expressed in males compared to females (in average 66%).
GRP is an interesting candidate for sex specific brain
development as expression of its receptor has been related
to the layering of cells in the chick telencephalon, optical
tectum and cerebellum [35]. The GnIH-RP2 peptide is
part of the gonadotropin inhibitory hormone (GnIH) pre-
cursor protein (UniProt GNIH_COTJA) whose main pep-
tide (GnIH) inhibits gonadotropin release in quail and is
strongly expressed in all avian species studied so far
[36,37]. The GnIH-RP2 peptide was significantly differen-
tially expressed between groups with a clear age effect
from ed12 to ed17 (Figure 4, Table 2). It also displayed sig-
nificant sex and interaction effects. It should be noted that
the identified sequence (ARSSIQSLLNLSQ) is actually
somewhat longer than the calculated GnIH-RP2 sequence
(SSIQSLLNLSQRF) and does not posses the characteristic
C-terminal RF-amide. The observed peptide may be part
of a larger propeptide-GNIH-RP2 peptide sequence that
has become degraded at both the N and C-terminal. The
GnIH precursor protein contains a neuropeptide cleavage
site (RxnR where n = 2, 4 or 6) [38] adjacent to a some-
what longer sequence (SPLARSSIQSLLNLSQ) of the pep-
tide in question (Table 2, Additional file 4). Unlike GnIH
itself, there is little known about the role of GnIH-RP pep-
tides. Although this may be the case, the overall expression
pattern of this particular peptide implies a biological role
in avian embryonic diencephalon development for GnIH-
RP2. Both GnIH-RP peptides posses affinity for the GnIH
receptor [39], indicating that GnIH-RP2 is involved in the
regulation of gonadotropin release from the developing
pituitary. NPK and GnIH-RP2 are both potential regula-
tors of gonadotropin regulation during diencephalon
development and the male HPG axis formation. The EE2
effects on GnIH-RP2 expression are not very influential/
statistical significant in either type of data analysis (multi-
variate or univariate) and therefore not conclusive. Still,
the fact that EE2 also seems to modulate GnIH-RP2
expression (Figure 4) is intriguing considering that the
NPK expression is EE2 sensitive. It could indicate that the
male quail embryonic window of sensitivity (regarding
adult male copulatory behavior) before and around ed12
to exogenous EE2 exposure is partly influenced by an
altered gonadotropin regulation and HPG axis formation.
It is important to note that this study is foremost of
hypothesis generating nature. We have analyzed the
expression of a large number of neuropeptides (including
detailed amino acid sequence information) under differ-
ent circumstances in the developing avian brain in a
manner that is impractical or impossible for the more
traditional immunoassay methods. Omics data is valuable
when the experimental design includes several variables
(in our case age, sex and EE2 exposure corresponding to
three variables or eight experimental groups) but requires
at the same time an increasing number of samples and
makes the analysis and presentation of the results more
difficult. Further studies are needed to better analyze the
role of the individual neuropeptides during development
using for instance more data points for age or the addi-
tion of aromatase inhibitors to better deduce the impact
of EE2. The absence of neuropeptides such as vasotocin
was for instance unexpected although this does not pro-
vide any conclusions on their presence or role in
Scholz et al. BMC Developmental Biology 2010, 10:30
http://www.biomedcentral.com/1471-213X/10/30
Page 11 of 16embryonic brain development. The absence of proof is
not the proof of absence. Peptides such as vasotocin con-
tain two cysteine amino acids and can contain a disulfide
bridge, a property that makes them more difficult to frag-
ment and identify with MS/MS. Additional peptides
could for instance be detectable in less hydrophilic sam-
ple preparation buffer settings than the weakly acidic
0.25% acetic acid buffer used in this study. Future pepti-
domics studies such as this study may provide even more
data when other sample preparations strategies or addi-
tional mass spectrometry systems besides LTQ-MS are
added.
Conclusion
To summarize, we report the first large scale neuropep-
tidomic analysis of the developing avian diencephalon at
ed12 and ed17 in Japanese quail, a common model for
studying sex-specific neural development. The pepti-
dome was analyzed in relation to age, sex and EE2 treat-
ment at ed3. Both age and EE2 treatment affected the
quail peptidome, without any clear discernible influence
of gender. A potential new avian neuropeptide candidate
was discovered in the secretogranin-2 precursor protein
and previously unknown phosphorylation sites in the
protachykinin C-terminal flanking peptide identified.
GnIH-RP2 and GRP are likely to be differentially
expressed in a sex specific manner and NPK in an EE2
sensitive manner during embryonic brain development
in Japanese quail. Our approach shows the strength of
labeling-free LC-MS peptidomics and how to better
characterize multiple known and unknown endogenous
peptides in the developing organism.
Methods
Embryos and sample collection
Fertilized Japanese quail (Coturnix coturnix japonica)
eggs were obtained from a local breeder. The eggs were
incubated at 37.5°C and 60% relative humidity and
turned every 3 h. On day three of incubation, eggs were
injected with 300 ng ethinylestradiol (EE2) each. The
EE2 was dissolved in an emulsion of peanut oil, lecithin,
and water [40]. Controls received emulsion only. The
holes in the shells were sealed with melted paraffin wax
and the eggs were returned to the incubator. The dien-
cephalon was excised as quickly as possible from
embryonic brains on ed12 and ed17 and was placed in
pre-weighed Eppendorf tubes. All samples were quickly
frozen in liquid nitrogen, a n ds t o r e da t- 8 0 ° C .T h e s e
samples were then used for neuropeptidomic analysis. A
tissue sample from each embryo was also collected for
DNA isolation and genetic sexing according to a PCR-
based method [41] in which intron sequences of differ-
ent lengths in the W-linked gene CHD1W (females) and
Z-linked gene CHD1Z (both sexes) are amplified. All
animal experiments were approved by the local Ethics
Committee for Animal Research, Uppsala, Sweden
(reference number C 198/6).
Sample preparation
Each frozen tissue sample was weighed and then placed
on aluminum foil and put into the Denator Stabilizer
Table 3 Sample annotation and run order design
Run order Sample Id Age Sex C/T Blocks
1 52a Ed17 Female C B1
2 65 Ed17 Male T
3 30 * Ed12 Female C
4 64 Ed17 Female T
5 10 * Ed12 Male T
6 27 Ed12 Male C
7 4 Ed12 Female T
8 52b Ed17 Female C
9 3 Ed12 Male T B2
10 23 Ed12 Male C
11 79 Ed17 Male T
12 9 Ed12 Female T
13 48 Ed17 Male C
14 78 Ed17 Female T
15 26 Ed12 Female C
16 54 Ed17 Female C
17 52c Ed17 Female C
18 12 Ed12 Male T B3
19 49 Ed17 Male C
20 57 Ed17 Female C
21 24 Ed12 Male C
22 19 Ed12 Female C
23 72 Ed17 Male T
24 80 Ed17 Female T
25 2 Ed12 Female T
26 52d Ed17 Female C
27 66 Ed17 Male T B4
28 6 Ed12 Male T
29 74 Ed17 Female T
30 29 Ed12 Male C
31 21 Ed12 Female C
32 55 Ed17 Female C
33 51 Ed17 Male C
34 7 Ed12 Female T
35 52e Ed17 Female C
36 1 Ed12 Male T B5
37 68 Ed17 Female T
38 56 Ed17 Male C
39 62 ^* Ed17 Female C
40 22 Ed12 Female C
41 25 Ed12 Male C
42 52f Ed17 Female C
* Samples that subsequently were removed as outliers.
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nology, Gothenburg, Sweden) for heat denaturation for
45 seconds to protect the samples from post mortem
protein degradation [42]. The order for denaturation of
the samples was randomized. The tissue samples were
then transferred to low-retention Eppendorf tubes and
suspended in pre-chilled extraction solution (0.25% acetic
acid; 0.2 mg tissue/μl) and homogenized by sonication
(Vibra cell 750, Sonics & Materials Inc., Newtown, CT,
USA) for 30 seconds [22,23]. Each sample suspension
was then centrifuged at 20,000 g for 30 minutes at 4°C to
remove insoluble material. The supernatant was trans-
ferred to Microcon 10 kDa cut-off spin columns (YM-10,
Millipore, Bedford, MA, US A )a n dc e n t r i f u g e df o r4 5
minutes at 14,000 g at 4°C. The resulting peptide filtrate
was then frozen at -80°C until analysis.
Experimental design
All samples were run in a complete randomized block
fashion with a total of five blocks (Table 3). Each block
included replicates of the same sample (Q52) that was
run repeatedly (six times, designated 52a-f). This
resulted in a total of 42 runs, using 37 unique samples.
MS analysis
Five μl of each sample was desalted on a Nano-Precol-
umn (LC Packings, Amsterdam, Netherlands) using
Ettan MDLC (GE Healthcare). The peptides were then
separated by a 40 minutes long run with a gradient
from 3 to 80% acetonitrile in 0.25% acetic acid on a 15
cm long Proxeon nanoESI emitter (75 μm inner dia-
meter, 360 μm outer diameter) packed in house with
Reprosil-Pur C18 3 μm resin (Dr. Maisch GmbH,
Ammerbuch-Entringen, Germany). At a flow rate of
approximately 150 nl/min the peptides were electro
sprayed into a linear ion trap mass spectrometer (LTQ,
Thermo Electron, San Jose, CA, USA). The spray voltage
was 1.8 kV, ES source capillary temperature was 160°C,
and 35 units of collision energy were used to obtain
peptide fragmentation tandem MS mode (MSMS). To
increase the number of identifications, eight μl of differ-
ent samples were also applied to an Agilent 1100 nano-
flow system coupled to a 7-tesla hybrid LTQ Fourier
transform ion cyclotron resonance (FTICR) MS
(Thermo Electron, Bremen, Germany) equipped with a
nanoelectrospray ion source (Proxeon Biosystems,
Odense, Denmark) as described previously [43]. Mass
spectrometric experiments were performed using unat-
tended data-dependent acquisition in which the mass
spectrometer automatically switches between a high
resolution survey scan (r 100.000), (accuracy 5 ppm) fol-
lowed by consecutive ECD and CAD fragmentation (r
25.000), (accuracy 0.02 Da) of the two most abundant
multiply charged peptides eluting at this moment from
the nano-LC column. Additional experiments were per-
formed where the precursor masses were as previously
detected with high mass accuracy (accuracy 0.02 Da),
but the fragmentation was performed solely in the LTQ
(accuracy 0.5 Da). Highmass accuracy spectra were dei-
sotoped and filtered using the peptide window approach
[43]. Detection of phosphorylated peptides was per-
formed by PhosTShunter [44]. Raw MS data associated
with the study may be downloaded from ProteomCom-
mons.org Tranche network https://proteomecommons.
org/index.jsp using the following hash:
Vui+Q2v4uXpRm2sWc5j8N3aNn+JISmG2RW9gnN
Mx0hBsse7DGTF3s7e+ci3lpmHUVsTuOKvvQTer
SKqe5X3uzYSGbaUAAAAAAAAYWg==
Peptide identification
The raw LTQ-MS data was converted to dta files by
Xcalibur 1.4 SR1 and assembled by an in-house devel-
oped script to Mascot generic files. These files were
searched against downloaded peptide rodent databases
from the SwePep endogenous peptide database [45] and
a precleaved chicken protein database derived from the
NCBI RefSeq database. The pre-cleavage was performed
as described by Fälth et al [24]. Estimation of false posi-
tives was conducted by searching all spectra against
reversed databases [24]. Searches using MASCOT [46]
and X! Tandem [47] (included in the Global Proteome
Manager, GPM) against the previously mentioned data-
bases were performed while checking for potential mod-
ifications (M oxidation, C-terminal amidation, Q/N
deamidation, STY phosphorylations and N-terminal
acetylation). Fragment mass error tolerance for both X!
Tandem and MASCOT was set at 0.7 Da and the parent
mass error was set to ± 1.5 Da. Two phosphorylated
peptides were detected and characterized with FTICR
MS and MASCOT as described above.
LC-MS image analysis
All LTQ-data files were imported into the DeCyder soft-
ware (version 2.0) for peak detection (PepDetect) and
spot matching between samples (PepMatch). PepDetect
parameters for peak detection were “Typical peak width:
0.2 min”, “Ion-trap mass resolution: 0.7 u”, “charge
states: 1-10”. All files were background corrected using
a smooth surface model. Identities from the MASCOT
and X! Tandem searches were incorporated into the
DeCyder image files. Peaks that were not present after
the initial DeCyder spot detection were added manually
for all files.
Removal of outliers
MS-data file outliers (see also table 3) were visually
detected by the presence of increased protein degrada-
tion (Q62), i.e., more peptide peaks, or general low ion
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Page 13 of 16intensity (Q10 and Q30), the later by PCA analysis (see
below). Removal of sample outliers left 39 MS-data files,
of which six were technical replicates (ed12 female con-
trol; Q52a-Q52f) to each other, corresponding to 34
unique samples.
Data normalization and analysis
Sample Q62 was removed from the data set before data
normalization and analysis due to increased degradation.
Ion intensity peptide match data was then exported for
further data analysis. The resulting data was log2 trans-
formed. In order to correct for global intensity differ-
ences between peptide runs the data was normalized in
two steps as previously described [48]. A linear regression
was fitted for each individual run to a median run that
were constructed of all median peptide values for pep-
tides that were matched in > 50% of all runs. Based on
the linear regression equation new values were predicted
for each run. A locally-weighted polynomial regression
(Lowess) was then fitted for each matched peptide
against the run order and the mean value across all runs
were added to retain the native intensity dimension. For
each matched peptide a proportion of 0.5 neighbors
(runs), weighted by their distance to the measurement,
were used for controlling the smoothness of the fit.
The data was grouped into eight groups: ed12 male
controls (ed12MC, n = 5), ed12 female controls
(ed12FC, n = 5), ed12 male EE2 (ed12ME, n = 5), ed12
female EE2 (ed12FE, n = 4), ed17 male controls
(ed17MC, n = 4)), ed17 female controls (ed17FC, n = 4),
ed17 male EE2 (ed17ME, n = 4), and ed17 female EE2
(ed17FE, n = 5) (Table 4). A minimum matching cut-off
(max one missing file per group) resulted in 204 pep-
tides. All 204 peptides had been manually inspected to
control for mismatching. An unsupervised multivariate
analysis by principal component analysis (PCA) using
the SIMCA-P software (version 12, Umetrics AB, Umeå,
Sweden) indicated previously mentioned Q10 (ed12ME)
and Q30 (ed12FC) to be outliers which led them to be
removed. Characterization of normalized log2 peptide
ion intensities was performed by hierarchical clustering
in the PermutMatrix program [49] using complete link-
age and Euclidian distance as the distance metric. To
better visualize age differences, the median value from
the log2 ion intensities for each peptide and group
(xclass: ed12MC, ed12FC, ed12ME, ed12FE, ed17MC,
ed17FC) was calculated and compared to the total aver-
age (xtot) ion intensity for each peptide (xclass-xtot). A
PCA model with two principal components (C1-C2)
explained ~42% of the variation in the data (R2X =
0.421; Q2X = 0.298), Eigen values for the components
being 11 (C1), 3.33 (C2) (Additional file 1). No pattern-
ing was discovered for sex, leaving age and EE2 (corre-
sponding to four classes in the data; combined male and
female ed12C, ed12E, ed17C and ed17E) as parameters
for further supervised multivariate analysis. An opti-
mized class separation based on the two variables of age
and EE2 (corresponding to four classes: ed12C, ed12E,
ed17C and ed17E) exposure was conducted by means of
Partial Least Square Discriminant Analysis (PLS/DA).
The age & EE2 PLS/DA resulted in a model with three
components (DC1-3; Eigen values 11, 2.62 and 2.12)
explaining ~72% of the variation in the data (R2X =
0.464; Q2X = 0.367 and R2Y = 0.722, Additional file 2).
See also additional file 3 for additional information. The
most influential peptides for the separation of the four
classes were identified by calculating the VIP (variable
importance in the projection). Peptides with large VIP,
larger than 1, are the most relevant for explaining the
separation. Confidence intervals for VIP were derived
from jack knifing. Both PCA and PLS/DA models were
optimized using Q2 cross validation scores and had the
Hotelling’sT
2 tolerance region set at 95% and the
DmodX critical distance (Dcrit) set to 0.05. The median
log2 ion intensity value for each peptide from the six
technical replicates (Q52a-Q52f) was used for both PCA
and PLS/DA analysis.
To test for differences in peptide expression between
groups (not including outlier samples Q10, Q30 and
Q62) and using the median value of the six technical
Table 4 Experimental groups and PLS/DA classes for age and EE2 exposure
Experimental
groups
No
Individuals
1
PLS/DA
classes
2
ed12 male controls (ed12MC) 5 ed12C
ed12 female controls (ed12FC) 4
ed12 male EE2 (ed12ME) 4 ed12E
ed12 female EE2 (ed12FE) 4
ed17 male controls (ed17MC) 4 ed17C
ed17 female controls (ed17FC) 4
ed17 male EE2 (ed17ME) 4 ed17E
ed17 female EE2 (ed17FE) 5
1. Not including technical replicates, and outliers Q62, Q10 and Q30
2. Partial Least Square Discriminant Analysis
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Page 14 of 16replicates (Q52a-Q52f)) a linear model was employed
estimating the effects of the fixed effects age, sex and
treatment. The linear model used was:
y A S T AS AT ST AST ijkl i j k ij ik jk ijk ijkl          () () () ( )
where μ was the average peptide expression, Ai repre-
sented the age factor (i = 12,17), Sj the sex factor
(j =M ,F ) ,Tk the treatment factor (k =C ,T )a n dASij,
ATik, STjk and ASTijk the interaction factors and εijkl was
the NID(0, s
2) error component. Marginal sum of
squares were calculated for main effects and interaction
effects. An F-test was performed to test the significance
of the model and the p-values were adjusted for multi-
ple testing [50]. The joint significance of all interaction
terms was tested using Wald F-test. Least squares
means for statistical significant (p < 0.05) main effects
were calculated (see additional file 4). For pair wise
t-testing, three levels of statistical significance were
u s e d :p<0 . 0 5( * ) ,p<0 . 0 1( * * )a n dp<0 . 0 0 1( * * * )( s e e
Additional file 5). The nlme [51] library available in the
R [52] software was used for the statistical analysis. Fol-
low up comparative sequence analysis for specific pep-
tides was done using BLAST 2 sequences alignment and
ClustalW.
Additional file 1: PCA images. PCA of peptide data with associated
Eigen values, and SIMCA Q2 prediction values (cumulative and
component specific). Shows how additional principal components relate
to the first two in predictive power.
Additional file 2: PLS/DA goodness of prediction (Q2X) plot for age
and EE2 effects. PLS/DA data including Eigen values, and SIMCA Q2
prediction values (cumulative and component specific). Shows how
additional principal components relate to the first three in predictive
power.Click here for file
Additional file 3: Ed12 PCA, PLS/DA and Coomans’ plots for EE2
effects. Data on how EE2 exposure influences the separation of samples
at ed12 and ed17. A, Coomans’ plots based on ed12 and ed17 PCA
models indicate that ed12 is associated with a more distinct EE2 effect.
B, and C, PLS/DA models of ed12 and ed17 also indicate that ed12 is
more distinct in its EE2 effects and that the top candidate peptide
influencing ed12 EE2 effects is NPK.Click here for file
Additional file 4: Preproenkephalin and GnIH-RP2 peptides.
Alignment of identified Japanese quail peptide sequences to precursor
protein sequences for Preproenkephalin and GnIH and annotation of
likely neuropeptide cleavage sites.Click here for file
Additional file 5: F-statistics. Table with statistic data values.Click here
for file
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